Renal monoclonal immunoglobulin deposition disease: The disease spectrum

Journal of the American Society of Nephrology

Volumn 12, Issue 7, 2001, Pages 1482-1492

  Lin, J ^a   Markowitz, G S ^a   Valeri, A M ^a   Kambhan, N ^a   Sherman, W H ^a   Appel, G B ^a   D'Agati, V D ^a  

^a New York Presbyterian Hospital Columbia University Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PARAPROTEIN; VIRUS ANTIBODY;

ARTICLE; CLINICAL ARTICLE; DYSPROTEINEMIA; FEMALE; HUMAN; HUMAN TISSUE; HYPERTENSION; HYPOCOMPLEMENTEMIA; IMMUNOFLUORESCENCE; IMMUNOGLOBULIN DEPOSITION; KIDNEY BIOPSY; KIDNEY DISEASE; MALE; MONOCLONAL IMMUNOGLOBULIN DEPOSITION DISEASE; MULTIPLE MYELOMA; PRIORITY JOURNAL; PROTEINURIA;

EID: 0034911594     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Nonamyloidic monoclonal immunoglobulin deposition disease
2. Light chain nephropathy: Histological and clinical aspects in 15 cases
3. Light chain nephropathy
4. Visceral deposition of monoclonal light chains and immunoglobulins: A study of renal and immunopathologic abnormalities
5. Monoclonal immunoglobulin deposition disease: Light chain and light and heavy chain deposition disease and their relation to light chain amyloidosis
6. Light-heavy chain deposition disease progressing to multiple myeloma
7. Heavy chain deposition disease: The disease spectrum
8. Heavy-chain deposition disease
9. Pseudo-heavy chain (IgG4) deposition disease
10. Crescenteric nodular glomerulosclerosis secondary to truncated immunoglobulin α deposition
11. Long-term outcome according to renal histological lesions in 118 patients with monoclonal gammopathies
12. Heavy chain deposition disease: Recurrence in a renal transplant and report of IgG 2 subtype
13. Nodular glomerulosclerosis with deposition of monoclonal immunoglobulin heavy chains lacking CH1
14. Structure of abnormal heavy chains in human heavy-chain-deposition disease
15. Long-term follow-up and response to chemotherapy in patients with light-chain deposition disease
16. Preferential expression of human κ-light-chain variable-region subgroups in multiple myeloma, AL-amyloidosis, and Waldenstrom's macroglobulinemia
17. Overrepresentation of the VκIV subgroup in light chain deposition disease
18. Structure of abnormal heavy chains in human heavy-chain-deposition disease
19. Growth factors in monoclonal light-chain related renal disease
20. Disappearance of nodular mesangial lesions in a patient with light chain nephropathy after long-term chemotherapy